// App-Quantinova.ai

: Effect of erdosteine in moderately severe COPD patients

Researchers

Presenter

  • Peter M.A. Calverley

Principal Investigators

  • Clive Page

  • Roberto W. Dal Negro

  • Giovanni Fontana

  • Martin Iversen

  • Arrigo F Cicero

  • Edoardo Pozzi

  • Jadwiga A. Wedzicha

Medical Centers

  • Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Aintree, United Kingdom

  • Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom

  • National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy

  • Pulmonology Department, Cough Center, Careggi University Hospital, Firenze, Italy

  • Division of Lung Transplantation, Rigshospitalet, University Hospital, Copenhagen, Denmark

  • Medical and Surgical Department, University of Bologna, Bologna, Italy

  • Medical Affairs Department, Edmond Pharma, Paderno Dugnano, Italy

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

  • Italy

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Erdosteine

  • Proglumide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved